Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Dermatologic Therapy|March 6, 2008
Prurigo nodularis and lichen simplex chronicusTorello Lotti, Gionata Buggiani, Francesca Prignano
Dermatologic Therapy|April 27, 2010
The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?Torello Lotti, Jana Hercogova, Francesca Prignano
Acta Bio-Medica : Atenei Parmensis|August 27, 2009
Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patientsFrancesca Prignano, Gionata Buggiani, Torello Lotti
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 24, 2018
Hidradenitis suppurativa and associated diseasesLeonardo Pescitelli, Federica Ricceri, Francesca Prignano
Dermatologic Therapy|December 17, 2008
Efalizumab in the treatment of psoriasis: when comorbidity is an issueFrancesca Prignano, Gionata Buggiani, Torello Lotti
Italian Journal of Dermatology and Venereology|November 3, 2025
Label and off-label treatment of dermatological diseases with JAK and TYK inhibitorsCarlo Pipitò, Andrea Marino, Francesca Prignano
Journal of Electron Microscopy|January 5, 2008
Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?Francesca Prignano, Christine M Betts, Torello Lotti
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2024
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativaAntonella Di Cesare, Elia Rosi, Francesca Prignano
Expert Opinion on Biological Therapy|September 5, 2020
Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilarsFrancesca Prignano, Jaeyun Choi, Burkhard Pieper, et al.
Biologics : Targets & Therapy|August 27, 2009
Efalizumab-induced severe thrombocytopenia can be resolvedFrancesca Prignano, F Zanieri, S Mokhtarzadeh, et al.
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Dermatologic Therapy|March 6, 2008
Prurigo nodularis and lichen simplex chronicusTorello Lotti, Gionata Buggiani, Francesca Prignano
Dermatologic Therapy|April 27, 2010
The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?Torello Lotti, Jana Hercogova, Francesca Prignano
Acta Bio-Medica : Atenei Parmensis|August 27, 2009
Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patientsFrancesca Prignano, Gionata Buggiani, Torello Lotti
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 24, 2018
Hidradenitis suppurativa and associated diseasesLeonardo Pescitelli, Federica Ricceri, Francesca Prignano
Dermatologic Therapy|December 17, 2008
Efalizumab in the treatment of psoriasis: when comorbidity is an issueFrancesca Prignano, Gionata Buggiani, Torello Lotti
Italian Journal of Dermatology and Venereology|November 3, 2025
Label and off-label treatment of dermatological diseases with JAK and TYK inhibitorsCarlo Pipitò, Andrea Marino, Francesca Prignano
Journal of Electron Microscopy|January 5, 2008
Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?Francesca Prignano, Christine M Betts, Torello Lotti
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2024
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativaAntonella Di Cesare, Elia Rosi, Francesca Prignano
Expert Opinion on Biological Therapy|September 5, 2020
Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilarsFrancesca Prignano, Jaeyun Choi, Burkhard Pieper, et al.
Biologics : Targets & Therapy|August 27, 2009
Efalizumab-induced severe thrombocytopenia can be resolvedFrancesca Prignano, F Zanieri, S Mokhtarzadeh, et al.
Pageof 20